Gennex Laboratories Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20	Mar ' 19

Sources of funds

Owner's fund

Equity share capital

18.02

12.65

12.65

12.65

12.65

Share application money

-

-

-

-

-

Preference share capital

-

-

-

-

-

Reserves & surplus

61.00

31.35

27.24

23.20

21.35

Loan funds

Secured loans

0.98

10.12

7.36

4.98

4.54

Unsecured loans

-

-

-

-

0.05

Total

80.00

54.12

47.25

40.84

38.59

Uses of funds

Fixed assets

Gross block

32.62

30.61

30.34

30.26

29.97

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

17.44

16.92

16.22

15.33

14.33

Net block

15.18

13.70

14.13

14.93

15.64

Capital work-in-progress

-

-

-

-

-

Investments

8.26

7.01

7.01

7.01

7.01

Net current assets

Current assets, loans & advances

72.78

47.50

37.95

35.19

29.26

Less : current liabilities & provisions

16.22

14.09

11.83

16.29

13.32

Total net current assets

56.56

33.41

26.12

18.90

15.94

Miscellaneous expenses not written

-

-

-

-

-

Total

80.00

54.12

47.25

40.84

38.59

Notes:

Book value of unquoted investments

8.26

7.01

7.01

7.01

7.01

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

0.74

0.74

1.70

1.60

1.57

Number of equity sharesoutstanding (Lacs)

1766.43

1265.03

1265.03

1265.03

1265.03